title: Possible mechanism for inhibition of morphine formation from 6-acetylmorphine after intake of street heroin.
abstract: Heroin is de-acetylated in the body to morphine in two steps. The intermediate 6-acetylmorphine (6-AM) is formed rapidly and is considered important for the pharmacological effect of heroin. In urine drug testing, an atypical pattern of morphine and 6-AM is known to occur in low frequency. The aim of this study was to investigate this atypical pattern in more detail and to identify responsible substances for a possible inhibition of the conversion from 6-AM to morphine. Urine samples were selected from a routine flow of samples sent for drug testing. Out of 695 samples containing morphine and 6-acetylmorphine, 11.5% had the atypical pattern of a 6-AM to morphine ratio above 0.26 as derived from a bimodal frequency distribution. An in vitro study of the conversion of 6-acetylmorphine to morphine in human liver homogenates demonstrated that a number of known carboxylesterase inhibitors were able to inhibit the reaction mimicking the situation in vivo. Compound 3 (3,6-Dimethoxy-4-acetoxy-5-[2-(N-methylacetamido)ethyl]phenanthrene) a substance formed from thebaine during the production of heroin was found to be a strong inhibitor. Liquid chromatography-mass spectrometry was used to identify possible inhibitors present in vivo. This part of the investigation demonstrated that several components may contribute to the effect. It is concluded that inhibition of liver carboxylesterase activity is a possible mechanism causing the atypical pattern and that one candidate compound is the result of the heroin production process. An inhibition of 6-AM metabolism is likely to increase the pharmacological effect of heroin and may be related to a higher risk of lethal toxicity.
authors.affiliation: Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institute, Stockholm, Sweden. Electronic address: maria.ch.andersson@karolinska.se.
authors.forename: Maria
authors.initials: M
authors.lastname: Andersson
authors.affiliation: Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institute, Stockholm, Sweden.
authors.forename: Linda
authors.initials: L
authors.lastname: Björkhem-Bergman
authors.affiliation: Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institute, Stockholm, Sweden.
authors.forename: Olof
authors.initials: O
authors.lastname: Beck
mesh_terms: D002110:Caffeine / Q000494:pharmacology; D043182:Carboxylesterase / Q000037:antagonists & inhibitors; D002492:Central Nervous System Depressants / Q000494:pharmacology; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D002853:Chromatography, Liquid; D000431:Ethanol / Q000494:pharmacology; D053593:Forensic Toxicology; D006556:Heroin Dependence; D006801:Humans; D008099:Liver / Q000201:enzymology; D013058:Mass Spectrometry; D009020:Morphine / Q000737:chemistry* / Q000652:urine; D009022:Morphine Derivatives / Q000737:chemistry* / Q000652:urine; D009294:Narcotics / Q000494:pharmacology; D020156:Salicylic Acid / Q000494:pharmacology; D013797:Thebaine / Q000494:pharmacology
chemical_list: D002492:Central Nervous System Depressants; D000697:Central Nervous System Stimulants; D009022:Morphine Derivatives; D009294:Narcotics; D013797:Thebaine; D002110:Caffeine; D000431:Ethanol; D009020:Morphine; D043182:Carboxylesterase; C026979:6-O-monoacetylmorphine; D020156:Salicylic Acid
keywords: 6-acetylmorphine; Heroin; Inhibition; LC–MS/MS; Metabolism; Morphine